Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT07572266

Adjuvant Nitrate to Boost Exercise-induced Health Benefits in Older Adults

Conditions: Aging, Aging Well, Healthy Aging

Sex: All
Ages: 60 Years – N/A
Healthy volunteers: Yes
Phase: NA
Enrollment: 226
Sponsor: Florida Institute for Human and Machine Cognition

Location: Florida Institute for Human and Machine Cognition Pensacola Florida

Summary

Aging-related functional declines are thought to be caused by hallmark biological processes that ultimately manifest in physical, mental, and metabolic impairments to compromise intrinsic capacity and healthspan. Exercise is the only multipotent treatment with promise to mitigate many of the aging hallmarks, but there is substantial variability in individual exercise responsiveness. Thus, the investigators approach to boosting exercise responsiveness in aging is to combine an exercise training prescription containing both endurance and resistance training (in alignment with DHHS guidelines) with a nitrate-enriched dietary supplement to augment the cellular, tissue, and systemic adaptations that induce myriad health benefits of exercise in older adults.

Eligibility Criteria

Inclusion Criteria: 1. Male or female aged 60 years or older 2. Free of chronic disease or disorder that would preclude full participation or have the potential to confound results 3. No structured exercise program (2 or more bouts/wk) within previous 12 months 4. Cognitively capable of providing informed consent Exclusion Criteria: 1. BMI ≥ 30.0 kg/m2 2. Neurodegenerative disease 3. Neuromuscular, musculoskeletal or orthopedic disorder or condition that would limit ability to perform the exercise prescription and/or physical performance testing 4. Diagnosed orthostatic hypotension, i.e., a drop in systolic blood pressure of at least 20 mmHg or a drop in diastolic blood pressure of at least 10 mmHg within three minutes of standing up from a sitting or lying position. 5. Resting blood pressure \160/95 mmHg 6. Uncontrolled hypertension 7. Any current cardiovascular disease or cardiopulmonary instability 8. Recent cardiovascular event or procedure within the preceding 6 months 1. If valve replacement has been performed, patient may not be enrolled for 12 months after the procedure 2. Any mechanical valve replacement that requires continuous warfarin anti-coagulation 9. Anemia: Hgb \7.0% or fasting blood glucose ≥ 130 mg/dl 11. Liver disease with ALT \> 52 U/l) 12. Chronic kidney disease (eGFR \< 45) 13. Any current infectious disease 14. Any other disease or disorder that could influence exercise response, preclude full participation or have the potential to confound results (e.g., chronic lung disease, cognitive impairment, current cancer diagnosis or within 2 yr remission, cerebrovascular disease, pain) 15. Life expectancy \< 1 year Medications / lifestyle 16. Insulin sensitizing/blood glucose lowering agents such as metformin 17. Currently on or have used GLP-1 agonist or other metabolic / weight loss drug in previous 12 weeks 18. Use of nitrate medications 19. High dose statin (≥40 mg/d simvastatin equivalence) 20. Chronic corticosteroids 21. Testosterone or other anabolic/androgenic hormone therapy 22. Lidocaine allergy 23. Regular tobacco use and/or vaping \> 1/wk 24. Use of cannabis \> 1/wk 25. Excessive alcohol consumption (3 drinks/d or 7 drinks/wk for females; 4 drinks/d or 14 drinks/wk for males) 26. Use of illicit drugs (e.g., cocaine, opioids) 27. Unable to commit to \~4 months required to complete the study

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07572266). StuddyBuddy aggregates publicly available trial information.